Press Release

NeoImmuneTech to Present at 2022 Biotech Showcase at J.P. Morgan Healthcare Conference


NeoImmuneTech, Inc.  (KOSDAQ: 950220), a clinical-stage T cell-focused biopharmaceutical company, today announced that its Chief Business Officer, Sam Zhang, Ph.D., MBA, will present at the upcoming Biotech Showcase at J.P. Morgan Healthcare Conference, to be held in a virtual format from January 10-12 and 17-19.
The details of the company’s Biotech Showcase presentation are as follows:
Date: Tuesday, January 11, 2022
Time: 10:00am PT

The company’s presentation will also be available on demand throughout the duration of the conference.